Ipamorelin 2mg (Euro-Pharmacies, Europe)

Ipamorelin is an intriguing new development in muscle building that is garnering significant interest within the bodybuilding community. Similar to the GHRP-6 peptide (growth hormone releasing hexapeptide), it is a synthetic peptide known for its potent Growth Hormone releasing effects. These GH releasing effects are particularly appealing to athletes and bodybuilders, as they can greatly enhance muscle growth and accelerate fat loss.

Users typically administer Ipamorelin in dosages ranging from 200 mcg to 300 mcg, two to three times a day, using a small insulin syringe for injection. Many begin with a lower dosage due to potential side effects, which may include headaches or sensations akin to a head rush. Ipamorelin can be taken at any time, but it appears most beneficial when administered approximately 30-45 minutes prior to a workout, as this timing optimizes the pulse of Growth Hormone (GH) for maximum muscle growth.

Research examining Ipamorelin's impact on bone growth, body weight, and GH release has yielded some noteworthy findings.

In one study, varying doses were given over a period of 15 days to observe the group's responses.

A clear and dose-dependent relationship was noted regarding body weight gain; however, the treatment group did not experience any change in total IGF-I levels, nor did they show increased serum markers for bone development. For instance, the quantity of cells in the wider section of the tibia (the shinbone) did not significantly alter. This is advantageous as it indicates muscle growth without increasing the risk of bone or cartilage deformities.

The pituitary's response to a high intravenous dose of Ipamorelin demonstrated a marked reduction in plasma GH levels, while levels remained stable after a similar dose of GHRH. This is a positive outcome, as it suggests that Ipamorelin does not inhibit the body’s natural GH production, further establishing it as a selective GH releaser.